Phase 3 programs underway for DURAVYU in wet AMD and DME, the largest multi-billion-dollar retinal disease markets –– Pivotal Phase 3 trials in ...

LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology ...

Phase 3 programs underway for DURAVYU in wet AMD and DME, the largest multi-billion-dollar retinal disease markets - - Pivotal Phase 3 trials in wet AMD on track for data readout beginning in mid-2026 ...

TH103 showed mean 10-letter gain in visual acuity and rapid, robust anatomic improvement at Month 1, following a single injection TH103 was generally well tolerated, supporting further dose escalation ...

Detailed price information for Kalaris Therapeutics Inc (KLRS-Q) from The Globe and Mail including charting and trades.

Advanced biomechanical modeling shows that early mammal ancestors likely used an eardrum to hear airborne sounds 250 million ...

Researchers have developed a light-activatable prodrug nanomedicine for age-related macular degeneration (AMD) therapy. Through the intravenous injection of the nanomedicine and application of light ...

This has been quite the wild year in human evolution stories. Our relatives, living and extinct, got a lot of attention—from ...

Approaching her 91st birthday, Dame Judi Dench has offered a poignant insight into her worsening eyesight, describing the decline as "crushing". The beloved actress, who was first diagnosed with ...

Contaminated drinking water in Indore, India, was linked to 10 deaths and more than 270 hospitalizations, according to ...

I am a 76-year-old male who is in relatively good health. For the past six months, I have been experiencing diarrhea on and ...

It’s that time of the year when PBS News Hour invites two of our regular literary critics, Ann Patchett and Maureen Corrigan, to highlight their favorite books of the year. Jeffrey Brown picks up the ...